An updated analysis of two large randomized clinical trials has found that breast cancer patients who received the monoclonal antibody trastuzumab (Herceptin) along with chemotherapy are living longer and with less risk of recurrent disease, compared to patients treated with chemotherapy alone.
Risk of congestive heart failure in women treated with trastuzumab (Herceptin) and combination chemotherapy for early-stage breast cancer did not increase over time according to a five-year follow-up of National Surgical Adjuvant Breast and Bowel Project (NSABP) trial B-31, presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Januvia (scientific name sitagliptin), a new drug designed to improve blood sugar control in patients with type 2 diabetes, should not be used because the drug?s long-term safety is still unknown, Public Citizen writes in a new June posting on its WorstPills.org Web site.
A simple exercise test may help predict mortality risk in patients with heart failure and help doctors to better tailor treatment strategies, according to new research from Wake Forest University Baptist Medical Center.
The U.S. Food and Drug Administration (FDA) issued a safety alert on Avandia, diabetes drug approved to treat type 2 diabetes. I believe safety alert on Glaxo’s diabetes drug Avandia is a timely action by US FDA health agency, remarked Dr. Anil Singhal.
The Food and Drug Administration (FDA) knew nearly five years ago about the dangers associated with the diabetes drug Avandia, an internal FDA memo shows.
Evidence confirms Public Citizen?s warnings about the risks of popular diabetes drug Avandia. Statement given by Sidney Wolfe, MD, Director of Health Research Group at Public Citizen:
The U.S. Food and Drug Administration (FDA) is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes.
Doctors at UPMC have begun a study using an investigational cardiac device, the VentrAssist? Left Ventricular Assist System (LVAD) to see whether it can be used safely and effectively in patients with end-stage heart failure.
Millions of Americans take medications for hypertension but do not achieve control of their blood pressure. Single-tablet combinations of drugs may be what it takes to get blood pressure under control, even in people with moderate hypertension, according to results from a new international study involving more than 10,700 people with high blood pressure.